Janus Henderson Group PLC Supernus Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,254 shares of SUPN stock, worth $750,871. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,254
Previous 23,254
-0.0%
Holding current value
$750,871
Previous $725,000
15.86%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding SUPN
# of Institutions
302Shares Held
60.7MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$199 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$156 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$92.9 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$84.9 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.73B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...